Shankar Musunuri, MBA, PhD

Malvern, Pennsylvania, United States
Dr. Musunuri is a seasoned biotech veteran with about 30+ years of results-driven experience advancing and commercializing a diverse portfolio of products. Prior to co-founding Ocugen in 2013, Dr. Musunuri held leadership roles at numerous companies ranging from “Big Pharma” to novel start-up biotechs. After a long tenure at Pfizer, he founded Nuron Biotech, Inc., which he grew to a commercial company in less than three years, serving as President and CEO. Dr. Musunuri spent nearly fifteen years at Pfizer, where he gained extensive product launch and life-cycle management experience, playing a key role as Global Operations Team Leader for the most successful launch in vaccine history, Prevnar 13®.

Dr. Musunuri obtained his PhD in Pharmaceutical Sciences from the University of Connecticut and an MBA from Duke University’s Fuqua School of Business.
Speaking In
11:00 AM - 11:15 AM (EST)
Monday, February 6
Ocugen, Inc. is a biotechnology company focused on discovering, developing, and commercializing…
Winter Garden